Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Chen

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Neuro-Oncology|March 4, 2021
Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancerWeijun Wang, Haiping He, Nagore I Marín-Ramos, et al.
Neuro-Oncology|September 3, 2020
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeuticsWeijun Wang, Nagore I Marín-Ramos, Haiping He, et al.
Molecular Cancer Therapeutics|April 14, 2007
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxibPeter Pyrko, Adel Kardosh, Yen-Ting Liu, et al.
Neuro-Oncology Advances|February 19, 2021
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastomaAxel H Schönthal, David M Peereboom, Naveed Wagle, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Journal of Craniovertebral Junction & Spine|October 20, 2023
Using machine learning and big data for the prediction of venous thromboembolic events after spine surgery: A single-center retrospective analysis of multiple models on a cohort of 6869 patientsBenjamin S Hopkins, Michael B Cloney, Ekamjeet S Dhillon, et al.
Molecular Cancer Therapeutics|August 31, 2012
Perillyl alcohol for the treatment of temozolomide-resistant gliomasHee-Yeon Cho, Weijun Wang, Niyati Jhaveri, et al.
International Journal of Molecular Sciences|February 26, 2020
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma ModelShih-Han Chen, Jui-Ming Sun, Bing-Mao Chen, et al.
JNCI Cancer Spectrum|March 27, 2020
Association Between Outdoor Air Pollution and Risk of Malignant and Benign Brain Tumors: The Multiethnic Cohort StudyAnna H Wu, Jun Wu, Chiuchen Tseng, et al.
CNS Oncology|August 31, 2018
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4<sup>+</sup> T-lymphocyte countsDaniela A Bota, Jinah Chung, Manisha Dandekar, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Neuro-Oncology|March 4, 2021
Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancerWeijun Wang, Haiping He, Nagore I Marín-Ramos, et al.
Neuro-Oncology|September 3, 2020
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeuticsWeijun Wang, Nagore I Marín-Ramos, Haiping He, et al.
Molecular Cancer Therapeutics|April 14, 2007
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxibPeter Pyrko, Adel Kardosh, Yen-Ting Liu, et al.
Neuro-Oncology Advances|February 19, 2021
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastomaAxel H Schönthal, David M Peereboom, Naveed Wagle, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Journal of Craniovertebral Junction & Spine|October 20, 2023
Using machine learning and big data for the prediction of venous thromboembolic events after spine surgery: A single-center retrospective analysis of multiple models on a cohort of 6869 patientsBenjamin S Hopkins, Michael B Cloney, Ekamjeet S Dhillon, et al.
Molecular Cancer Therapeutics|August 31, 2012
Perillyl alcohol for the treatment of temozolomide-resistant gliomasHee-Yeon Cho, Weijun Wang, Niyati Jhaveri, et al.
International Journal of Molecular Sciences|February 26, 2020
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma ModelShih-Han Chen, Jui-Ming Sun, Bing-Mao Chen, et al.
JNCI Cancer Spectrum|March 27, 2020
Association Between Outdoor Air Pollution and Risk of Malignant and Benign Brain Tumors: The Multiethnic Cohort StudyAnna H Wu, Jun Wu, Chiuchen Tseng, et al.
CNS Oncology|August 31, 2018
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4<sup>+</sup> T-lymphocyte countsDaniela A Bota, Jinah Chung, Manisha Dandekar, et al.
Pageof 15